Today’s top gainers include the company Celgene Corporation (NASDAQ:CELG) which is in the industry Biotechnology, gaining 2.10% today. In the last week its performance is 4.58%, and -0.35% for the past quarter. Currently, Celgene Corporation, CELG has a target price of 136.38, so today’s gain of 2.10% is a significant step towards its target price. The GAP today is therefore -0.10%.
Celgene Corporation (NASDAQ:CELG), has a market cap of 78606.42, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 80.40%.
At the current price of 100.7, it has a dividend yield of *TBA, and its target price is 136.38. This is with a profit margin of 17.40%, and total debt/equity of 0. Celgene Corporation (NASDAQ:CELG) has a P/E of 48.72, as well as a forward P/E of 14.4.
With a current EPS of 2.07, and a forecasted EPS growth for next year at 23.32%,Celgene Corporation (NASDAQ:CELG) has had a EPS growth for the past five years at 15.70%. For the next five years EPS growth is projected to be 22.06%.
Performance for the year is -15.75%. Since its IPO date on 3/26/1990, the total performance to date is -15.92%.
Volume today for Celgene Corporation (NASDAQ:CELG), is 3410367, while its average volume is 4418.02. Whilst the total gain today was 2.10%, it did have a day high of -10.01%.
Volatility for this week has been at 2.33%, and 2.34% for the month. The 52-week low for Celgene Corporation, CELG has been 8.30%, while the 52-week-high has reached -28.44%.
Looking at its return of investments, which is 8.90%, and its return on assets is 6.90%. Celgene Corporation (NASDAQ:CELG) has an operating margin of 24.50%. With a sales growth of 20.70% quarter over quarter. Bearing in mind that Celgene Corporation, CELG is in the sector Healthcare, its long-term debt/equity is 2.81, and has a current ratio of 4.6 and 4.3 for quick ratio.
So what is the value of Celgene Corporation? Well its PEG is 2.21, and the P/S is 8.11, along with a P/B of 15.49. Meanwhile it has a p/cash of 13.77.